1-20 of 29
Vamsi Kota, MBBS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tyrosine Kinase Inhibitor Therapy Discontinuation in Clinical Practice in Chronic Myeloid Leukemia - a US Physician Survey Conducted after Guideline Updates

Ehab L. Atallah, MD, Islam Sadek, Xiting Cao, Dominick Latremouille-Viau, Irina Pivneva, PhD, Carmine Rossi, Annie Guerin, Vamsi Kota, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2208.
https://doi.org/10.1182/blood-2019-125736
Published: 2019
Journal Articles

Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integrated Results from a Phase 1/2a and an Ongoing Phase 2b

Jessica K. Altman, Tsila Zuckerman, MD, Olga Frankfurt, MD, Selina M. Luger, MD FRCPC, Dale L. Bixby, MD, Vamsi Kota, MBBS, Micah M. Burch, Ofir Wolach, Itai Levi, MD, Anna Gourevitch, Ron Ram, MD, Liat Flaishon, Shoshi Tessler, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M. Rowe, MB, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 179.
https://doi.org/10.1182/blood-2019-124330
Published: 2019
Journal Articles

Optimize the Patient to Optimize the Therapy: Role of Prephase Cyclophosphamide in Aggressive Lymphoma

Nabin Karki, MBBS, Vamsi Kota, MBBS, Katherine Saunders, PharmD, Cara Iacobellis, PharmD, Anand Jillella, MD, Germame Ajebo, MD, Locke J. Bryan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5294.
https://doi.org/10.1182/blood-2019-129644
Published: 2019
Journal Articles

Social Media Network Utility in Disease Education: Experience from a CML-Disease Awareness Medical Education Program

Ehab L. Atallah, MD, Vamsi Kota, MBBS, Islam Sadek, Andrea Damon, PhD, Ji-May Jen, PharmD, Berna Cakmak, BPharm, Joshua Landy, MD FRCPC, Sharon Vorona, MBBS, Jerald P. Radich, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5842.
https://doi.org/10.1182/blood-2019-124809
Published: 2019
Journal Articles

Efficacy and Safety Following Dose Reduction of Bosutinib or Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia: Analysis of the Phase 3 BFORE Trial

Tim H. Brummendorf, MD, Carlo Gambacorti-Passerini, MD, Andreas Hochhaus, MD, Jeff H. Lipton, MD PhD, Vamsi Kota, MBBS, Michael W. Deininger, MD PhD, Eric Leip, PhD, Andrea Viqueira, MD, Roxanne Ferdinand, MBBS MFPM, Jorge E. Cortes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3005.
https://doi.org/10.1182/blood-2018-99-110543
Published: 2018
Journal Articles

A Nationwide Analysis of Outcomes of Stroke in Hospitalized Patients with Essential Thrombocythemia: 2006 to 2014

Germame Ajebo, MD, Kristine Badin, MD, William Forehand, MD, Achuta Kumar Guddati, MD PhD, Vamsi Kota, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4293.
https://doi.org/10.1182/blood-2018-99-116065
Published: 2018
Journal Articles

Analysis of Outcomes in Hospitalized Pregnant Patients with Acute Myeloid Leukemia

Achuta Kumar Guddati, MD PhD, Anand Jillella, MD, Vamsi Kota, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 3595.
https://doi.org/10.1182/blood-2018-99-118583
Published: 2018
Journal Articles

Outcomes of Hospitalized Patients with Myocardial Infarction and Immune Thrombocytopenic Purpura: A Cross Sectional Study over 15 Years

Chisom Onuoha, MD, Marcus Weldon, MD, Vamsi Kota, MBBS, Achuta Kumar Guddati, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4977.
https://doi.org/10.1182/blood-2018-99-116966
Published: 2018
Journal Articles

Bosutinib or Imatinib in Older Vs Younger Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Phase 3 BFORE Trial

Michael W. Deininger, MD PhD, Vamsi Kota, MBBS, Jeff H. Lipton, MD PhD, Dragana Milojkovic, MBBS, PhD, Valentín García Gutiérrez, PhD, Eric Leip, PhD, Sonja Nick, MSc, Andreas Hochhaus, MD, Carlo Gambacorti-Passerini, MD, Jorge E. Cortes, MD, Tim H. Brummendorf, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1734.
https://doi.org/10.1182/blood-2018-99-110798
Published: 2018
Journal Articles

Healthcare Costs in Elderly Patients with Acute Myeloid Leukemia (AML) in Routine Clinical Care in the United States (US)

Jill A Bell, PhD, Aaron Galaznik, MD, Sharanya Murty, PhD, Megan Pollack, PharmD, Augustina Ogbonnaya, MPH, Michael T. Eaddy, PharmD, PhD, Robert J. Fram, MD, Douglas V. Faller, MD PhD, Vamsi Kota, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 3459.
https://doi.org/10.1182/blood.V130.Suppl_1.3459.3459
Published: 2017
Journal Articles

Comorbid Conditions in Newly Diagnosed Patients with Acute Promyelocytic Leukemia (APL) in "Real World" Patients; Decreased Induction Mortality Despite a High Comorbid Index

Stephanie Debragga, Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Sheldon Bolds, Catherine R. Caprara, MSN, NP, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 3379.
https://doi.org/10.1182/blood.V130.Suppl_1.3379.3379
Published: 2017
Journal Articles

Availability of ATRA, Blood BANK Support, Treatment Protocols and Hematologists/Oncologists for Management of APL in Two States (MICHIGAN AND LOUSIANA)

Sheldon Bolds, Shruthi M.K Hassan, Catherine R. Caprara, MSN, NP, Stephanie Debragga, Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Arpita Gandhi, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 5620.
https://doi.org/10.1182/blood.V130.Suppl_1.5620.5620
Published: 2017
Journal Articles

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Vamsi Kota, MBBS, Martha L. Arellano, MD, Prachi Kharkhanis, Sheldon Bolds, Catherine R. Caprara, MSN, NP, Kathryn Sarah Simon, PA-C, Stephanie Debragga, Manila Gaddh, MD, Leon Bernal-Mizrachi, MD, Leonard Heffner, MD, Elliott F. Winton, MD, Morgan L. McLemore, MD, Amelia Langston, MD, Zaid Al-Kadhimi, MD, Asad Bashey, MD PhD, Robert K. Stuart, MD, Asim Pati, MD, Jonathan M. Gerber, MD, Michael Richard Grunwald, MD, Kyle Bradley, MD MS, Jose Tongol, MD, Mohamed El-Geneidy, Amber Clemmons, Anand Jillella, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5667.
https://doi.org/10.1182/blood.V130.Suppl_1.5667.5667
Published: 2017
Journal Articles

Treatment Characteristics and Outcomes for Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia (AML) Treated in the United States with Either 7+3 or a Hypomethylating Agent (HMA)

Jill A Bell, PhD, Aaron Galaznik, MD, Eileen Farrelly, MPH, Sharanya Murty, PhD, Augustina Ogbonnaya, MPH, Michael T. Eaddy, PharmD, PhD, Robert J. Fram, MD, Douglas V. Faller, MD PhD, Vamsi Kota, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 2167.
https://doi.org/10.1182/blood.V130.Suppl_1.2167.2167
Published: 2017
Journal Articles

A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia

Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Stephanie Debragga, Sheldon Bolds, Saleh Alghsoon, Martha L. Arellano, MD, Ravindra Kolhe, MD PhD, Anand Jillella, MD, Vamsi Kota, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4869.
https://doi.org/10.1182/blood.V130.Suppl_1.4869.4869
Published: 2017
Journal Articles

Results from the U.S. Life after Stopping TKIs (LAST) Study

Ehab Atallah, MD, Charles A. Schiffer, MD, Jerald P. Radich, MD, Kevin Weinfurt, PhD, Mei-Jie Zhang, PhD, Vamsi Kota, MBBS, Javier Pinilla-Ibarz, MD PhD, Joseph O. Moore, MD, Richard A. Larson, MD, Vivian Oehler, MD, Michael J. Mauro, MD, Michael W. Deininger, MD PhD, James E. Thompson, MD, Neil P. Shah, MD PhD, Martha Wadleigh, MD, Ellen K Ritchie, MD, Richard T Silver, MD, Jorge E. Cortes, MD, Arielle Baim, Mary M. Horowitz, MD MS, Kathryn Flynn, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2903.
https://doi.org/10.1182/blood.V130.Suppl_1.2903.2903
Published: 2017
Journal Articles

Outcomes of Chronic Phase Chronic Myeloid Leukemia (CP-CML) after Sequential Treatment with Tyrosine Kinase Inhibitors (TKI)

Jee Hyun Kong, Elliott F. Winton, MD, Leonard Heffner, MD, Manila Gaddh, MD, Brittany Hill, PA-C, MMSc, MSc, MPH, Martha L. Arellano, MD, Fuad El-Rassi, Audrey Kim, Vamsi Kota, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 5247.
https://doi.org/10.1182/blood.V130.Suppl_1.5247.5247
Published: 2017
Journal Articles

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Vamsi Kota, MBBS, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Sheldon Bolds, Stephanie Debragga, Kathryn Sarah Simon, PA-C, Martha L. Arellano, MD, Anand Jillella, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5017.
https://doi.org/10.1182/blood.V130.Suppl_1.5017.5017
Published: 2017
Journal Articles

Molecular Characterization By Cancer Immune Profiling in Acute Promyelocytic Leukemia (APL) May Identify Patients at Risk of Early Death

Ravindra Kolhe, MD PhD, Chetan Pundkar, DVM, Ashis Mondal, PhD, Jeremy Pantin, MBBS, Vamsi Kota, MBBS, Amber Clemmons, Anand Jillella, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4976.
https://doi.org/10.1182/blood.V130.Suppl_1.4976.4976
Published: 2017
Journal Articles

Acute Promyelocytic Leukemia (APL) Induction Therapy and Incidence of Renal Insufficiency

Prachi Kharkhanis, Sheldon Bolds, Stephanie Debragga, Catherine R. Caprara, MSN, NP, Kathryn Sarah Simon, PA-C, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 5020.
https://doi.org/10.1182/blood.V130.Suppl_1.5020.5020
Published: 2017